CL
Colgate-Palmolive Company
—
89.48 $
-1.1000 (%-1.21)
Previous Close: 90.58
Day Low₺89.45
Day High₺91.34
CL: Colgate-Palmolive Company Financials
CL Income Statement
Total revenue
Net income
Gross margin TTM
60.11%
Operating margin TTM
21.33%
Net profit margin TTM
10.46%
Return on investment TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 20,382,000,000 | 20,101,000,000 | 19,457,000,000 | 17,967,000,000 |
| Operating income | 4,348,000,000 | 4,383,000,000 | 4,131,000,000 | 3,585,000,000 |
| Net income | 2,132,000,000 | 2,889,000,000 | 2,300,000,000 | 1,785,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 20,382,000,000 | 20,101,000,000 | 19,457,000,000 | 17,967,000,000 |
| Cost of revenue | 8,131,000,000 | 7,995,000,000 | 8,206,000,000 | 7,817,000,000 |
| Gross profit | 12,251,000,000 | 12,106,000,000 | 11,251,000,000 | 10,150,000,000 |
| Research and development expenses | 0 | 355,000,000 | 343,000,000 | 320,000,000 |
| General and administrative expenses | 0 | 5,090,000,000 | 0 | 0 |
| Selling and marketing expenses | 0 | 2,720,000,000 | 0 | 0 |
| Selling, general and administrative expenses | 7,903,000,000 | 7,810,000,000 | 6,777,000,000 | 6,245,000,000 |
| Other expenses | 0 | -442,000,000 | 0 | 0 |
| Operating expenses | 7,903,000,000 | 7,723,000,000 | 7,120,000,000 | 6,565,000,000 |
| Cost and expenses | 16,034,000,000 | 15,718,000,000 | 15,326,000,000 | 14,382,000,000 |
| Net interest income | -192,000,000 | -225,000,000 | -232,000,000 | -153,000,000 |
| Interest income | 75,000,000 | 67,000,000 | 55,000,000 | 14,000,000 |
| Interest expense | 267,000,000 | 292,000,000 | 287,000,000 | 167,000,000 |
| Depreciation and amortization | 630,000,000 | 605,000,000 | 567,000,000 | 545,000,000 |
| EBITDA | 3,956,000,000 | 4,853,000,000 | 4,246,000,000 | 3,372,000,000 |
| EBIT | 3,326,000,000 | 4,248,000,000 | 3,679,000,000 | 2,827,000,000 |
| Non-operating income (excl. interest) | 1,022,000,000 | 135,000,000 | 452,000,000 | 758,000,000 |
| Operating income | 4,348,000,000 | 4,383,000,000 | 4,131,000,000 | 3,585,000,000 |
| Total other income/expenses (net) | -1,289,000,000 | -427,000,000 | -739,000,000 | -925,000,000 |
| Income before tax | 3,059,000,000 | 3,956,000,000 | 3,392,000,000 | 2,660,000,000 |
| Income tax expense | 798,000,000 | 907,000,000 | 937,000,000 | 693,000,000 |
| Net income from continuing operations | 2,261,000,000 | 3,049,000,000 | 2,455,000,000 | 1,967,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 2,132,000,000 | 2,889,000,000 | 2,300,000,000 | 1,785,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 2,132,000,000 | 2,889,000,000 | 2,300,000,000 | 1,785,000,000 |
| EPS | 3 | 4 | 3 | 2 |
| Diluted EPS | 3 | 4 | 3 | 2 |
| Weighted average shares outstanding | 808,700,000 | 817,700,000 | 827,400,000 | 836,400,000 |
| Weighted average diluted shares outstanding | 811,100,000 | 822,500,000 | 829,200,000 | 838,800,000 |